David Shook, MD
Nkarta, Inc. · St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Shook, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:40 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05020678 · NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell CancersNkarta, Inc. · active not recruiting · Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma · study director
- Ph1NCT04623944 · NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDSNkarta, Inc. · active not recruiting · Relapsed/Refractory AML, AML, Adult, MDS · study director
- Ph1NCT00995137 · Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital · completed · Lymphoblastic Leukemia, Acute · principal investigator
- Ph1NCT00640796 · Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid TumorsSt. Jude Children's Research Hospital · completed · Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, T-Cell, Juvenile Myelomonocytic Leukemia Lymphoblastic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cell Therapy of Refractory LeukemiaR01CA113482 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DARIO CAMPANA · fiscal years 2006 to 2010Named on NCT00995137, NCT00640796
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.